Issued Patents All Time
Showing 1–25 of 53 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12419893 | Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine | Brian D. Frenzel, Philip Liaw | 2025-09-23 |
| 12194043 | Uridine phosphorylase inhibitors to treat or prevent pulmonary disease | Philip Liaw, Brian D. Frenzel | 2025-01-14 |
| 12109222 | Methods and compositions for treating mucositis | Brian D. Frenzel, Philip Liaw | 2024-10-08 |
| 11945803 | Modulators of RAS GTPase | Annie L. Lennek, Stephen D. Yanofsky, Brian D. Frenzel, Solomon Ungashe, Philip Liaw | 2024-04-02 |
| 11446303 | Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions | Heshan Peiris, Philip Liaw, Brian D. Frenzel | 2022-09-20 |
| 11390626 | Pyrazolopyrimidine modulators of RAS GTPase | Solomon Ungashe, Stephen D. Yanofsky, Philip Liaw, Annie L. Lennek | 2022-07-19 |
| RE48253 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel, Travis Karg | 2020-10-13 |
| 10660318 | Non-mammalian RAS transgenic animal model | Travis Karg, Steve Yanofsky | 2020-05-26 |
| 9468613 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel | 2016-10-18 |
| 9382287 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel, Travis Karg | 2016-07-05 |
| 9274129 | Methods and reagents for detecting bioactive lipids | Roger A. Sabbadini, Genevieve Hansen | 2016-03-01 |
| 9217749 | Immune-derived moieties reactive against lysophosphatidic acid | Roger A. Sabbadini, Genevieve Hansen | 2015-12-22 |
| 9181331 | Pharmaceutical compositions for binding sphingosine-1-phosphate | Roger A. Sabbadini, Scott R. Pancoast, Genevieve Hansen, Marina Yu SAFONOV | 2015-11-10 |
| 9163091 | Compositions and methods for binding lysophosphatidic acid | Roger A. Sabbadini, Genevieve Hansen, James Stephen SWANEY, Rosalia MATTEO, Gordon MILLS +1 more | 2015-10-20 |
| 9061038 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel | 2015-06-23 |
| 8853227 | Methotrexate adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel, Travis Karg | 2014-10-07 |
| 8796429 | Bioactive lipid derivatives, and methods of making and using same | Roger A. Sabbadini, Genevieve Hansen | 2014-08-05 |
| 8614103 | Compositions and methods for treating sphingosine-1-phosphate (S1P) related ocular diseases and conditions | Roger A. Sabbadini, Glenn L. Stoller | 2013-12-24 |
| 8604172 | Humanized antibody compositions and methods for binding lysophosphatidic acid | Roger A. Sabbadini, Genevieve Hansen, Steven Jones, David G. Williams | 2013-12-10 |
| 8444970 | Compositions and methods for treating ocular diseases and conditions | Roger A. Sabbadini, Glenn L. Stoller | 2013-05-21 |
| 8361465 | Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents | Roger A. Sabbadini | 2013-01-29 |
| 8227517 | Doxorubicin adjuvants to reduce toxicity and methods for using the same | Brian D. Frenzel | 2012-07-24 |
| 8222373 | Humanized antibodies and compositions for binding sphingosine-1-phosphate | Roger A. Sabbadini, Genevieve Hansen, Steven Jones, David G. Williams | 2012-07-17 |
| 8158124 | Compositions and methods for binding lysophosphatidic acid | Roger A. Sabbadini, Genevieve Hansen, James Stephen SWANEY | 2012-04-17 |
| 8138356 | Chemical inhibitors of inhibitors of differentiation | Jaideep Chaudhary | 2012-03-20 |